Royal Bank of Canada
DXCM icon

Royal Bank of Canada’s DexCom DXCM Stock Holding History

Royal Bank of Canada’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$124M Sell
1,974,424
-565,324
-22% -$39.4M 0.02% 568
2025
Q4 		$169M Sell
2,539,748
-622,905
-20% -$40.3M 0.03% 479
2025
Q3 		$213M Buy
3,162,653
+1,100,272
+53% +$87.1M 0.03% 412
2025
Q2 		$180M Buy
2,062,381
+59,659
+3% +$4.68M 0.03% 424
2025
Q1 		$137M Buy
2,002,722
+506,907
+34% +$41.4M 0.03% 445
2024
Q4 		$116M Buy
1,495,815
+484,658
+48% +$35.9M 0.02% 524
2024
Q3 		$67.8M Sell
1,011,157
-213,520
-17% -$17.5M 0.01% 683
2024
Q2 		$139M Buy
1,224,677
+248,056
+25% +$31.4M 0.03% 428
2024
Q1 		$135M Sell
976,621
-353,484
-27% -$44.4M 0.03% 414
2023
Q4 		$165M Buy
1,330,105
+336,896
+34% +$34.4M 0.04% 379
2023
Q3 		$92.7M Sell
993,209
-591,495
-37% -$66.7M 0.03% 491
2023
Q2 		$204M Buy
1,584,704
+857,741
+118% +$104M 0.05% 308
2023
Q1 		$84.5M Sell
726,963
-156,673
-18% -$17.5M 0.02% 500
2022
Q4 		$100M Buy
883,636
+210,075
+31% +$23.1M 0.03% 466
2022
Q3 		$54.3M Buy
673,561
+143,904
+27% +$12.2M 0.02% 612
2022
Q2 		$39.5M Sell
529,657
-179,503
-25% -$16.4M 0.01% 757
2022
Q1 		$90.7M Buy
709,160
+157,844
+29% +$17.3M 0.02% 532
2021
Q4 		$74M Sell
551,316
-48,220
-8% -$6.93M 0.02% 637
2021
Q3 		$82M Sell
599,536
-109,952
-15% -$13.9M 0.02% 563
2021
Q2 		$75.7M Buy
709,488
+155,032
+28% +$14.9M 0.02% 577
2021
Q1 		$49.8M Sell
554,456
-15,888
-3% -$1.49M 0.01% 706
2020
Q4 		$52.7M Buy
570,344
+143,188
+34% +$12.8M 0.02% 688
2020
Q3 		$44M Buy
427,156
+19,964
+5% +$2.09M 0.02% 669
2020
Q2 		$41.3M Buy
407,192
+38,044
+10% +$3.4M 0.02% 651
2020
Q1 		$24.9M Sell
369,148
-28,444
-7% -$1.77M 0.01% 786
2019
Q4 		$21.7M Sell
397,592
-75,544
-16% -$3.58M 0.01% 1113
2019
Q3 		$17.7M Sell
473,136
-12,584
-3% -$489K 0.01% 1159
2019
Q2 		$18.2M Sell
485,720
-24,620
-5% -$774K 0.01% 1163
2019
Q1 		$15.2M Sell
510,340
-26,224
-5% -$922K 0.01% 1242
2018
Q4 		$16.1M Sell
536,564
-17,072
-3% -$542K 0.01% 1132
2018
Q3 		$19.8M Buy
553,636
+43,480
+9% +$1.35M 0.01% 1138
2018
Q2 		$12.1M Sell
510,156
-32,740
-6% -$694K 0.01% 1399
2018
Q1 		$10.1M Buy
542,896
+55,400
+11% +$819K ﹤0.01% 1536
2017
Q4 		$7M Sell
487,496
-28,604
-6% -$372K ﹤0.01% 1841
2017
Q3 		$6.31M Buy
516,100
+77,860
+18% +$1.38M ﹤0.01% 1843
2017
Q2 		$8.01M Buy
438,240
+56,900
+15% +$1.05M ﹤0.01% 1648
2017
Q1 		$8.08M Sell
381,340
-162,548
-30% -$3.17M ﹤0.01% 1606
2016
Q4 		$8.12M Buy
543,888
+104,696
+24% +$1.85M ﹤0.01% 1641
2016
Q3 		$9.63M Buy
439,192
+385,460
+717% +$8.58M 0.01% 1503
2016
Q2 		$1.06M Buy
53,732
+8,564
+19% +$146K ﹤0.01% 3063
2016
Q1 		$767K Buy
45,168
+7,920
+21% +$132K ﹤0.01% 3290
2015
Q4 		$764K Buy
37,248
+15,484
+71% +$322K ﹤0.01% 3369
2015
Q3 		$467K Sell
21,764
-65,940
-75% -$1.47M ﹤0.01% 3581
2015
Q2 		$1.75M Buy
87,704
+12,452
+17% +$219K ﹤0.01% 2422
2015
Q1 		$1.17M Buy
75,252
+9,500
+14% +$144K ﹤0.01% 2721
2014
Q4 		$905K Buy
65,752
+46,460
+241% +$569K ﹤0.01% 3013
2014
Q3 		$193K Buy
19,292
+9,944
+106% +$102K ﹤0.01% 4209
2014
Q2 		$93K Sell
9,348
-53,380
-85% -$473K ﹤0.01% 4578
2014
Q1 		$648K Buy
62,728
+58,396
+1,348% +$604K ﹤0.01% 3142
2013
Q4 		$39K Sell
4,332
-4,676
-52% -$37K ﹤0.01% 4993
2013
Q3 		$63K Sell
9,008
-12,140
-57% -$76.9K ﹤0.01% 4712
2013
Q2 		$118K Buy
+21,148
New +$101K ﹤0.01% 4211

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Royal Bank of Canada's DXCM Position: Q1 2026 in Review

Royal Bank of Canada reduced its DexCom (DXCM) stake by 22% in Q1 2026, selling an estimated $39.4M and leaving 1,974,424 shares worth $124M. The position accounts for 0.02% of the portfolio, ranked #568.

Royal Bank of Canada first reported a position in DXCM in Q2 2013 and has held it in 52 quarters since. The position peaked at $213M in Q3 2025. 957 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Royal Bank of Canada held 1,974,424 shares of DexCom worth $124M as of Q1 2026.
  • Royal Bank of Canada sold 565,324 DexCom shares in Q1 2026, an estimated $39.4M.
  • DexCom made up 0.02% of Royal Bank of Canada's portfolio in Q1 2026, its #568 holding.
  • Royal Bank of Canada first reported a position in DexCom in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's DexCom position peaked at $213M in Q3 2025.
  • 957 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.